Trefoil peptides and surgical disease (Q33670774)

28 July 2017

1 reference

title

Trefoil peptides and surgical disease (English)

1 reference

28 July 2017

R J Longman

1

1 reference

28 July 2017

M G Thomas

series ordinal

2

1 reference

28 July 2017

R Poulsom

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

British Journal of Surgery

28 July 2017

published in

1 reference

28 July 2017

volume

86

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

740-748

1 reference

A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins).

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in 'gastric metaplasia' of the proximal duodenum: implications for the nature of 'gastric metaplasia'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Expression of the pNR-2/pS2 protein in diverse human epithelial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Expression of intestinal trefoil factor mRNA is downregulated during progression of colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

A third P-domain peptide gene (TFF3), human intestinal trefoil factor, maps to 21q22.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Effects of pancreatic spasmolytic Polypeptide (PSP) on epithelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Healing the epithelium: solving the problem from two sides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1999.01131.X

10.1046/J.1365-2168.1999.01131.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference